Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 8, 2000, Pages 2744-2747

  Finne, Patrik ^a   Auvinen, Anssi ^b,c   Koistinen, Hannu ^a   Zhang, Wan Ming ^a   Määttänen, Liisa ^c   Rannikko, Sakari ^a   Tammela, Teuvo ^e   Seppälä, Markku ^a   Hakama, Matti ^c,d   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; STATISTICAL ANALYSIS;

AGED; CONFIDENCE INTERVALS; FALSE POSITIVE REACTIONS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; ODDS RATIO; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 17744364495     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.8.2744     Document Type: Article

References (27)

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
2. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
3. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
4. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
5. Insulin-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia
6. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
7. Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence
8. Insulin-like growth factor binding protein-3: Biochemistry and physiology
9. Proteases acting on IGFBPs: Their occurrence and physiological significance
10. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
11. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
12. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen
13. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
14. Serum insulin-like growth factor-1 is not a useful marker of prostate cancer
15. European randomized study of prostate cancer screening: First-year results of the Finnish trial
16. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies
17. Determination of prostate volume by transrectal ultrasound
18. The meaning and use of the area under a receiver operating characteristic (ROC) curve
19. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects
20. Growth regulation of prostatic stromal cells by prostate-specific antigen
21. Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: A clinical trial
22. Trends in prostate cancer care in the United States, 1974-1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer
23. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
24. Prostate-specific antigen
25. Prostatic hyperplasia: An unknown feature of acromegaly